We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
ADA
SECTIONS
  • TISSUE
  • BRAIN
  • SINGLE CELL TYPE
  • TISSUE CELL TYPE
  • PATHOLOGY
  • DISEASE
  • IMMUNE CELL
  • BLOOD PROTEIN
  • SUBCELLULAR
  • CELL LINE
  • STRUCTURE
  • METABOLIC
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
  • SARS-COV-2
HELP
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • HELP & FAQ
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Class
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Patient ID
Tissue
Category
Cluster
Reliability
Brain region
Category
Brain region
Category
Brain region
Category
Reliability
Cell type
Category
Cluster
Tissue
Cell type
Enrichment
Cancer
Prognosis
Cancer
Category
Cell type
Category
Cell lineage
Category
Cluster
Annotation
Disease
Location
Searches
Location
Cell line
Type
Phase
Reliability
Cancer type
Category
Cluster
Pathway
Category
Score
Score
Score
Validation
Validation
Validation
Validation
Antibodies
Protein structure
In atlas
Column


  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • TISSUE CELL

  • PATHOLOGY

  • DISEASE

  • IMMUNE

  • BLOOD

  • SUBCELL

  • CELL LINE

  • STRUCTURE

  • METABOLIC

  • ADA
PROTEIN STRUCTURE
ANTIBODIES
AND
VALIDATION
Protein structures
GENERAL INFORMATIONi

General description of the gene and the encoded protein(s) using information from HGNC and Ensembl, as well as predictions made by the Human Protein Atlas project.

Gene namei

Official gene symbol, which is typically a short form of the gene name, according to HGNC.

ADA
Synonyms ADA1
Gene descriptioni

Full gene name according to HGNC.

Adenosine deaminase
Protein classi

Assigned HPA protein class(es) for the encoded protein(s).

Read more
Disease related genes
Enzymes
FDA approved drug targets
Human disease related genes
Metabolic proteins
Plasma proteins
Predicted locationi

All transcripts of all genes have been analyzed regarding the location(s) of corresponding protein based on prediction methods for signal peptides and transmembrane regions.

  • Genes with at least one transcript predicted to encode a secreted protein, according to prediction methods or to UniProt location data, have been further annotated and classified with the aim to determine if the corresponding protein(s) are secreted or actually retained in intracellular locations or membrane-attached.

  • Remaining genes, with no transcript predicted to encode a secreted protein, will be assigned the prediction-based location(s).

The annotated location overrules the predicted location, so that a gene encoding a predicted secreted protein that has been annotated as intracellular will have intracellular as the final location.

Read more
Intracellular
Protein evidence Evidence at protein level (all genes)
GENE INFORMATIONi

Gene information from Ensembl and Entrez, as well as links to available gene identifiers are displayed here. Information was retrieved from Ensembl if not indicated otherwise.

Chromosome 20
Cytoband q13.12
Chromosome location (bp) 44619522 - 44652233
Number of transcriptsi

Number of protein-coding transcripts from the gene as defined by Ensembl.

2
Ensembl ENSG00000196839 (version 103.38)
Entrez gene 100
HGNC HGNC:186
UniProt P00813 (UniProt - Evidence at protein level)
neXtProt NX_P00813
Antibodypedia ADA antibodies


PROTEIN STRUCTUREi

The Structure section provides predicted structures from the Alphafold protein structure database and available experimental structures from Protein Data Bank (PDB).

In the Structure drop-down menu all experimental structures from PDB are available for selection and display. The structures are displayed using the NGL Viewer and can be zoomed-in and rotated either manually or by checking the Autorotate box. The Color scheme can be selected to show the residue index, chain name or confidence score (as B-factors and pLDDT score for experimental and predicted structures, respectively). The positions for available antigen sequences in the structure are shown if Antigens is turned to ON, and the Variants slider can be used to show the positions of clinical and population variants.https://github.com/nglviewer/ngl

Read more

Predicted


Description: Structure prediction from Alphafold project. Structure version 2

# Chains: 1      # Clinical variants: 39      # Population variants: 252

Antigens:

Off
On

Variants:

Off
Clinical
Population

Color scheme:

Confidence
Residue index
Chain name

Autorotate:

Off
On



PROTEIN BROWSERi

The protein browser displays the antigen location on the target protein(s) and the features of the target protein. The tabs at the top of the protein view section can be used to switch between the different splice variants to which an antigen has been mapped.

At the top of the view, the position of the antigen (identified by the corresponding HPA identifier) is shown as a green bar. A yellow triangle on the bar indicates a <100% sequence identity to the protein target.

Below the antigens, the maximum percent sequence identity of the protein to all other proteins from other human genes is displayed, using a sliding window of 10 aa residues (HsID 10) or 50 aa residues (HsID 50). The region with the lowest possible identity is always selected for antigen design, with a maximum identity of 60% allowed for designing a single-target antigen (read more).

The curve in blue displays the predicted antigenicity i.e. the tendency for different regions of the protein to generate an immune response, with peak regions being predicted to be more antigenic.The curve shows average values based on a sliding window approach using an in-house propensity scale. (read more).

If a signal peptide is predicted by a majority of the signal peptide predictors SPOCTOPUS, SignalP 4.0, and Phobius (turquoise) and/or transmembrane regions (orange) are predicted by MDM, these are displayed.

Low complexity regions are shown in yellow and InterPro regions in green. Common (purple) and unique (grey) regions between different splice variants of the gene are also displayed (read more), and at the bottom of the protein view is the protein scale.
ADA-201
ADA-207


PROTEIN INFORMATIONi

The protein information section displays alternative protein-coding transcripts (splice variants) encoded by this gene according to the Ensembl database.

The ENSP identifier links to the Ensembl website protein summary, while the ENST identifier links to the Ensembl website transcript summary for the selected splice variant. The data in the UniProt column can be expanded to show links to all matching UniProt identifiers for this protein.

The protein classes assigned to this protein are shown if expanding the data in the protein class column. Parent protein classes are in bold font and subclasses are listed under the parent class.

The Gene Ontology terms assigned to this protein are listed if expanding the Gene ontology column. The length of the protein (amino acid residues according to Ensembl), molecular mass (kDalton), predicted signal peptide (according to a majority of the signal peptide predictors SPOCTOPUS, SignalP 4.0, and Phobius) and the number of predicted transmembrane region(s) (according to MDM) are also reported.
Splice variant UniProt Protein class Gene ontology Length & mass Signal peptide
(predicted)
Transmembrane regions
(predicted)
ADA-201
ENSP00000361965
ENST00000372874
P00813 [Direct mapping]
Adenosine deaminase
A0A0S2Z381 [Target identity:100%; Query identity:100%]
Adenosine aminohydrolase
Show all
Enzymes
   ENZYME proteins
   Hydrolases
Metabolic proteins
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Plasma proteins
Disease related genes
FDA approved drug targets
   Small molecule drugs
Human disease related genes
   Immune system diseases
   Primary immunodeficiency
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0001666 [response to hypoxia]
GO:0001701 [in utero embryonic development]
GO:0001821 [histamine secretion]
GO:0001829 [trophectodermal cell differentiation]
GO:0001883 [purine nucleoside binding]
GO:0001889 [liver development]
GO:0001890 [placenta development]
GO:0002314 [germinal center B cell differentiation]
GO:0002636 [positive regulation of germinal center formation]
GO:0002686 [negative regulation of leukocyte migration]
GO:0002906 [negative regulation of mature B cell apoptotic process]
GO:0004000 [adenosine deaminase activity]
GO:0005515 [protein binding]
GO:0005615 [extracellular space]
GO:0005737 [cytoplasm]
GO:0005764 [lysosome]
GO:0005829 [cytosol]
GO:0005886 [plasma membrane]
GO:0006154 [adenosine catabolic process]
GO:0006157 [deoxyadenosine catabolic process]
GO:0007155 [cell adhesion]
GO:0007568 [aging]
GO:0008270 [zinc ion binding]
GO:0009117 [nucleotide metabolic process]
GO:0009168 [purine ribonucleoside monophosphate biosynthetic process]
GO:0009897 [external side of plasma membrane]
GO:0009986 [cell surface]
GO:0010460 [positive regulation of heart rate]
GO:0016020 [membrane]
GO:0016787 [hydrolase activity]
GO:0019239 [deaminase activity]
GO:0030054 [cell junction]
GO:0030324 [lung development]
GO:0030890 [positive regulation of B cell proliferation]
GO:0031410 [cytoplasmic vesicle]
GO:0032261 [purine nucleotide salvage]
GO:0032839 [dendrite cytoplasm]
GO:0033089 [positive regulation of T cell differentiation in thymus]
GO:0033197 [response to vitamin E]
GO:0033632 [regulation of cell-cell adhesion mediated by integrin]
GO:0042110 [T cell activation]
GO:0042323 [negative regulation of circadian sleep/wake cycle, non-REM sleep]
GO:0042493 [response to drug]
GO:0042542 [response to hydrogen peroxide]
GO:0043025 [neuronal cell body]
GO:0043066 [negative regulation of apoptotic process]
GO:0043101 [purine-containing compound salvage]
GO:0043103 [hypoxanthine salvage]
GO:0043278 [response to morphine]
GO:0045187 [regulation of circadian sleep/wake cycle, sleep]
GO:0045580 [regulation of T cell differentiation]
GO:0045582 [positive regulation of T cell differentiation]
GO:0045987 [positive regulation of smooth muscle contraction]
GO:0046059 [dAMP catabolic process]
GO:0046061 [dATP catabolic process]
GO:0046085 [adenosine metabolic process]
GO:0046101 [hypoxanthine biosynthetic process]
GO:0046103 [inosine biosynthetic process]
GO:0046111 [xanthine biosynthetic process]
GO:0046638 [positive regulation of alpha-beta T cell differentiation]
GO:0046872 [metal ion binding]
GO:0048286 [lung alveolus development]
GO:0048541 [Peyer's patch development]
GO:0048566 [embryonic digestive tract development]
GO:0050728 [negative regulation of inflammatory response]
GO:0050850 [positive regulation of calcium-mediated signaling]
GO:0050862 [positive regulation of T cell receptor signaling pathway]
GO:0050870 [positive regulation of T cell activation]
GO:0060169 [negative regulation of adenosine receptor signaling pathway]
GO:0060205 [cytoplasmic vesicle lumen]
GO:0060407 [negative regulation of penile erection]
GO:0070244 [negative regulation of thymocyte apoptotic process]
GO:0070256 [negative regulation of mucus secretion]
Show all
363 aa
40.8 kDa
No 0
ADA-207
ENSP00000441818
ENST00000537820
F5GWI4 [Direct mapping]
Adenosine deaminase; Adenosine deaminase isoform 2
Show all
Metabolic proteins
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Human disease related genes
   Immune system diseases
   Primary immunodeficiency
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0005829 [cytosol]
GO:0005886 [plasma membrane]
GO:0009168 [purine ribonucleoside monophosphate biosynthetic process]
GO:0019239 [deaminase activity]
GO:0030054 [cell junction]
GO:0060205 [cytoplasmic vesicle lumen]
Show all
339 aa
38.3 kDa
No 0

Contact

  • NEWS ARTICLES
  • PRESS ROOM
  • contact@proteinatlas.org

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.